Financhill
Buy
77

MYO Quote, Financials, Valuation and Earnings

Last price:
$6.12
Seasonality move :
104.65%
Day range:
$6.00 - $6.31
52-week range:
$2.51 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.94x
P/B ratio:
19.92x
Volume:
330.8K
Avg. volume:
315.3K
1-year change:
50%
Market cap:
$185.1M
Revenue:
$19.2M
EPS (TTM):
-$0.23
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3.8M $7.6M $13.9M $15.6M $19.2M
Revenue Growth (YoY) 57.02% 97.6% 82.72% 12.26% 23.7%
 
Cost of Revenues $1.4M $2.6M $3.5M $5.3M $6.1M
Gross Profit $2.4M $5M $10.3M $10.3M $13.2M
Gross Profit Margin 62.98% 65.71% 74.42% 65.91% 68.51%
 
R&D Expenses $1.7M $1.7M $2.6M $2.5M $2.6M
Selling, General & Admin $11.5M $13.8M $18M $18.4M $18.8M
Other Inc / (Exp) $194.5K -$586.5K -$17K -$67.6K -$170.3K
Operating Expenses $13.2M $15.5M $20.6M $20.9M $21.4M
Operating Income -$10.8M -$10.5M -$10.3M -$10.7M -$8.2M
 
Net Interest Expenses $112.5K $474.7K -- -- --
EBT. Incl. Unusual Items -$10.7M -$11.6M -$10.3M -$10.7M -$8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $88.9K $69.9K $156K
Net Income to Company -$10.7M -$11.6M -$10.4M -$10.7M -$8.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$10.7M -$11.6M -$10.4M -$10.7M -$8.1M
 
Basic EPS (Cont. Ops) -$20.79 -$3.67 -$1.89 -$1.52 -$0.28
Diluted EPS (Cont. Ops) -$20.79 -$3.67 -$1.89 -$1.52 -$0.28
Weighted Average Basic Share $553.8K $3.3M $5.8M $7.1M $29.5M
Weighted Average Diluted Share $553.8K $3.3M $5.8M $7.1M $29.5M
 
EBITDA -$10.7M -$11M -$9.9M -$10.1M -$7.7M
EBIT -$10.8M -$11.1M -$10.3M -$10.7M -$8.2M
 
Revenue (Reported) $3.8M $7.6M $13.9M $15.6M $19.2M
Operating Income (Reported) -$10.8M -$10.5M -$10.3M -$10.7M -$8.2M
Operating Income (Adjusted) -$10.8M -$11.1M -$10.3M -$10.7M -$8.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.9M $4.4M $4M $5.1M $9.2M
Revenue Growth (YoY) 217.61% 127.54% -9.48% 28.01% 81.27%
 
Cost of Revenues $855.3K $1.1M $1.3M $1.6M $2.3M
Gross Profit $1.1M $3.3M $2.6M $3.5M $6.9M
Gross Profit Margin 55.61% 74.68% 66.45% 68.69% 75.43%
 
R&D Expenses $345.7K $641.2K $690.4K $717.3K $1.2M
Selling, General & Admin $3.3M $4.7M $4.8M $4.8M $6.7M
Other Inc / (Exp) -$188.3K -$4.1K -$21.7K -$70.6K --
Operating Expenses $3.6M $5.3M $5.5M $5.5M $7.9M
Operating Income -$2.5M -$2M -$2.8M -$2M -$957.6K
 
Net Interest Expenses $42K -- -- -- --
EBT. Incl. Unusual Items -$2.8M -$2M -$2.8M -$2M -$881.5K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2K $22.7K $23.4K $46.4K $84.9K
Net Income to Company -$2.8M -$2.1M -$2.8M -$2M -$966.4K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.8M -$2.1M -$2.8M -$2M -$966.4K
 
Basic EPS (Cont. Ops) -$0.70 -$0.36 -$0.40 -$0.06 -$0.03
Diluted EPS (Cont. Ops) -$0.70 -$0.36 -$0.40 -$0.06 -$0.03
Weighted Average Basic Share $3.9M $5.7M $7.1M $35.3M $38M
Weighted Average Diluted Share $3.9M $5.7M $7.1M $35.3M $38M
 
EBITDA -$2.7M -$1.9M -$2.7M -$1.9M -$836.3K
EBIT -$2.7M -$2M -$2.8M -$2M -$957.6K
 
Revenue (Reported) $1.9M $4.4M $4M $5.1M $9.2M
Operating Income (Reported) -$2.5M -$2M -$2.8M -$2M -$957.6K
Operating Income (Adjusted) -$2.7M -$2M -$2.8M -$2M -$957.6K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.3M $13.6M $15.5M $18.5M $25.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2M $3.6M $4.8M $5.8M $7.6M
Gross Profit $3.3M $10M $10.7M $12.7M $17.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.7M $2.2M $2.8M $2.3M $4.1M
Selling, General & Admin $13M $17M $19.1M $18.5M $22M
Other Inc / (Exp) -$535.2K -$23K -$61.9K -$108.1K -$64.4K
Operating Expenses $14.7M $19.2M $21.9M $20.7M $26.1M
Operating Income -$11.4M -$9.2M -$11.2M -$8M -$8.4M
 
Net Interest Expenses $692.1K $1.9K -- -- --
EBT. Incl. Unusual Items -$12.6M -$9.3M -$11.2M -$7.8M -$8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $63.8K $115.5K $61.9K $351.6K
Net Income to Company -$12.6M -$9.3M -$11.3M -$7.9M -$8.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$12.6M -$9.3M -$11.3M -$7.9M -$8.4M
 
Basic EPS (Cont. Ops) -$9.13 -$1.76 -$1.75 -$0.50 -$0.23
Diluted EPS (Cont. Ops) -$9.13 -$1.76 -$1.75 -$0.50 -$0.23
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$12.1M -$9M -$10.6M -$7.4M -$8M
EBIT -$12.2M -$9.3M -$11.2M -$8M -$8.4M
 
Revenue (Reported) $5.3M $13.6M $15.5M $18.5M $25.2M
Operating Income (Reported) -$11.4M -$9.2M -$11.2M -$8M -$8.4M
Operating Income (Adjusted) -$12.2M -$9.3M -$11.2M -$8M -$8.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.8M $9.8M $11.5M $14.5M $20.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.6M $2.6M $3.9M $4.4M $5.9M
Gross Profit $2.2M $7.2M $7.6M $10.1M $14.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.3M $1.8M $2M $1.8M $3.2M
Selling, General & Admin $9.8M $13M $14.1M $14.1M $17.3M
Other Inc / (Exp) -$573.7K -$10.2K -$55.2K -$106K --
Operating Expenses $11M $14.8M $16.1M $15.9M $20.5M
Operating Income -$8.8M -$7.6M -$8.5M -$5.8M -$6M
 
Net Interest Expenses $472.8K -- -- -- --
EBT. Incl. Unusual Items -$9.9M -$7.6M -$8.5M -$5.6M -$5.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.9K $66.6K $93.2K $85.2K $280.8K
Net Income to Company -$9.9M -$7.6M -$8.6M -$5.7M -$5.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$9.9M -$7.6M -$8.6M -$5.7M -$5.9M
 
Basic EPS (Cont. Ops) -$4.33 -$1.39 -$1.23 -$0.21 -$0.16
Diluted EPS (Cont. Ops) -$4.33 -$1.39 -$1.23 -$0.21 -$0.16
Weighted Average Basic Share $8.7M $16.5M $20.9M $87.5M $112.1M
Weighted Average Diluted Share $8.7M $16.5M $20.9M $87.5M $112.1M
 
EBITDA -$9.3M -$7.3M -$8.1M -$5.4M -$5.7M
EBIT -$9.4M -$7.6M -$8.5M -$5.8M -$6M
 
Revenue (Reported) $3.8M $9.8M $11.5M $14.5M $20.5M
Operating Income (Reported) -$8.8M -$7.6M -$8.5M -$5.8M -$6M
Operating Income (Adjusted) -$9.4M -$7.6M -$8.5M -$5.8M -$6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $4.5M $12.2M $15.5M $5.3M $6.9M
Short Term Investments -- -- -- -- $2M
Accounts Receivable, Net $424.3K $924.9K $2M $1.9M $2.4M
Inventory $439.5K $707.1K $808.3K $1.4M $1.8M
Prepaid Expenses $820.2K $572.7K -- -- --
Other Current Assets -- -- $799.2K $573.5K $598.9K
Total Current Assets $6.1M $14.4M $19.1M $9.2M $13.7M
 
Property Plant And Equipment $155K $263.8K $908.2K $703K $839.4K
Long-Term Investments -- -- -- $132.5K --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $75K -- $95.3K $111K $91.2K
Total Assets $6.6M $14.7M $20.1M $10.2M $14.6M
 
Accounts Payable $450.1K $180.5K $723.4K $569.7K $1.1M
Accrued Expenses $398.8K $586.9K $516.2K $662.6K $502K
Current Portion Of Long-Term Debt $1.8M -- -- -- --
Current Portion Of Capital Lease Obligations -- $18.3K $333.4K $353.7K $486.1K
Other Current Liabilities $378.2K -- -- -- --
Total Current Liabilities $3.9M $2.9M $4.3M $3.6M $5.5M
 
Long-Term Debt $889K -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $4.8M $3.1M $4.7M $3.8M $5.6M
 
Common Stock $60 $460 $690 $780 $2.7K
Other Common Equity Adj -- -$12.7K -$60.7K $43.2K $83.7K
Common Equity $1.8M $11.6M $15.4M $6.4M $9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.8M $11.6M $15.4M $6.4M $9M
 
Total Liabilities and Equity $6.6M $14.7M $20.1M $10.2M $14.6M
Cash and Short Terms $4.5M $12.2M $15.5M $5.3M $8.9M
Total Debt $2.7M -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $13.3M $12.6M $7.4M $6.9M $6.6M
Short Term Investments -- -- -- $4.2M --
Accounts Receivable, Net $308.5K $2.2M $1.6M $2.5M $3.7M
Inventory $759.8K $644.1K $1.5M $1.5M $3.4M
Prepaid Expenses $790.3K $994.1K $553.7K -- --
Other Current Assets -- -- -- $920.1K $968.6K
Total Current Assets $15.2M $16.5M $11.1M $16M $14.7M
 
Property Plant And Equipment $105.6K $998.5K $844.9K $887.9K $1M
Long-Term Investments -- -- $149.1K $32.7K --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $75K -- $111K $91.2K $580.4K
Total Assets $15.4M $17.5M $12.2M $17.1M $16.3M
 
Accounts Payable $331.9K $624.4K $878.6K $1.2M $1.3M
Accrued Expenses $538.9K $589.3K $560.6K $659K $530.5K
Current Portion Of Long-Term Debt $78.1K -- -- -- --
Current Portion Of Capital Lease Obligations -- $301.9K $441.4K $456.1K $205.5K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.2M $3.7M $4.1M $5.8M $7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $2.4M $4.3M $4.3M $6M $7M
 
Common Stock $460 $580 $710 $2.7K $3K
Other Common Equity Adj -- -$10.5K -$11.5K -$8.6K $395.7K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $13M $13.1M $7.8M $11M $9.3M
 
Total Liabilities and Equity $15.4M $17.5M $12.2M $17.1M $16.3M
Cash and Short Terms $13.3M $12.6M $7.4M $11.1M $6.6M
Total Debt $78K -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$10.7M -$11.6M -$10.4M -$10.7M -$8.1M
Depreciation & Amoritzation $95.1K $108.7K $336K $542.6K $517.7K
Stock-Based Compensation $908K $614.3K $1.1M $1.2M $1.1M
Change in Accounts Receivable -$42K -$522.9K -$1M $47.5K -$495.6K
Change in Inventories -$213.6K -$271.6K -$118.2K -$607.4K -$384.8K
Cash From Operations -$10.3M -$9M -$9.5M -$10.2M -$6.2M
 
Capital Expenditures $52K $45.8K $326.5K $111.8K $145.8K
Cash Acquisitions -- -- -- -$199K --
Cash From Investing -$52K -$45.8K -$326.5K -$310.8K -$2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.8M -- -- -- --
Long-Term Debt Repaid -- -$2M -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$73.4K $24K -- -- -$8.1K
Cash From Financing $8.3M $16.8M $13.2M $376.9K $9.7M
 
Beginning Cash (CF) $6.6M $4.5M $12.2M $15.5M $5.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.1M $7.7M $3.3M -$10.2M $1.5M
Ending Cash (CF) $4.5M $12.2M $15.5M $5.3M $6.9M
 
Levered Free Cash Flow -$10.4M -$9.1M -$9.9M -$10.3M -$6.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$2.8M -$2.1M -$2.8M -$2M -$966.4K
Depreciation & Amoritzation $26.7K $96.8K $140.1K $127.2K $121.2K
Stock-Based Compensation $181.7K $301.8K $305.6K $330.4K $324.2K
Change in Accounts Receivable $18K -$1.1M -$239.3K -$861.5K -$1M
Change in Inventories -$80.9K $80.9K -$256.2K -$159K -$757.1K
Cash From Operations -$1.8M -$2.2M -$2.8M -$1.7M -$1.5M
 
Capital Expenditures $22.4K $54.9K $5.7K $54.1K $320.7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$22.4K -$54.9K -$5.7K -$1.3M $2.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$1.2K -- -- -$199.5K
Cash From Financing $4.4M $1.1M -- $3.9M -$199.5K
 
Beginning Cash (CF) $10.8M $13.8M $10.2M $6M $5.8M
Foreign Exchange Rate Adjustment -$390 $230 -$11.4K -$13.9K $20.1K
Additions / Reductions $2.6M -$1.2M -$2.8M $919.4K $1.1M
Ending Cash (CF) $13.4M $12.6M $7.4M $6.9M $7M
 
Levered Free Cash Flow -$1.8M -$2.3M -$2.8M -$1.8M -$1.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$12.6M -$9.3M -$11.3M -$7.9M -$8.4M
Depreciation & Amoritzation $104.2K $250.7K $511.5K $582.7K $391.2K
Stock-Based Compensation $578.9K $1M $1.2M $1.1M $886.7K
Change in Accounts Receivable -$204.4K -$1.9M $598.5K -$940.9K -$986.4K
Change in Inventories -$235.2K $105.4K -$923.7K $55.2K -$1.9M
Cash From Operations -$10.5M -$8.9M -$9.6M -$6.3M -$9M
 
Capital Expenditures $44K $318K $132.3K $117.5K $531.5K
Cash Acquisitions -- -- -$199K -- --
Cash From Investing -$44K -$318K -$331.3K -$4.3M $3.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2M -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $12K -- -- -- --
Cash From Financing $19.6M $8.4M $4.8M $10.1M $5.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9M -$784.2K -$5.1M -$518.4K $58.7K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$10.6M -$9.2M -$9.7M -$6.4M -$9.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$9.9M -$7.6M -$8.6M -$5.7M -$5.9M
Depreciation & Amoritzation $79.7K $221.8K $397.4K $437.5K $310.9K
Stock-Based Compensation $411.2K $831K $917.1K $781.5K $552.6K
Change in Accounts Receivable $85.9K -$1.3M $362.8K -$625.6K -$1.1M
Change in Inventories -$324.2K $52.7K -$752.7K -$90.1K -$1.6M
Cash From Operations -$7.9M -$7.7M -$7.8M -$3.8M -$6.7M
 
Capital Expenditures $30.3K $302.6K $108.4K $114.2K $499.9K
Cash Acquisitions -- -- -$199K -- --
Cash From Investing -$30.3K -$302.5K -$307.4K -$4.3M $1.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2M -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $5.1K -- -- -$8.2K -$199.5K
Cash From Financing $16.8M $8.4M -- $9.7M $5.2M
 
Beginning Cash (CF) $29.2M $43.4M $38.7M $20.6M $18.2M
Foreign Exchange Rate Adjustment -$410 -$890 -$27.6K -$6.6K $6.4K
Additions / Reductions $8.9M $366.4K -$8.1M $1.6M $120K
Ending Cash (CF) $38M $43.8M $30.6M $22.2M $18.3M
 
Levered Free Cash Flow -$7.9M -$8M -$7.9M -$3.9M -$7.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock